Literature DB >> 16210316

Activation of the Src family kinase Hck without SH3-linker release.

Edwina C Lerner1, Ronald P Trible, Anthony P Schiavone, James M Hochrein, John R Engen, Thomas E Smithgall.   

Abstract

Src family protein-tyrosine kinases are regulated by intramolecular binding of the SH2 domain to the C-terminal tail and association of the SH3 domain with the SH2 kinase-linker. The presence of two regulatory interactions raises the question of whether disruption of both is required for kinase activation. To address this question, we engineered a high affinity linker (HAL) mutant of the Src family member Hck in which an optimal SH3 ligand was substituted for the natural linker. Surface plasmon resonance analysis demonstrated tight intramolecular binding of the modified HAL sequence to SH3. Hck-HAL was then combined with a tail tyrosine mutation (Y501F) and expressed in Rat-2 fibroblasts. Surprisingly, Hck-HAL-Y501F showed strong transforming and kinase activities, demonstrating that intramolecular SH3-linker release is not required for SH2-based kinase activation. In Saccharomyces cerevisiae, which lacks the negative regulatory tail kinase Csk, wild-type Hck was more strongly activated in the presence of an SH3-binding protein (human immunodeficiency virus-1 Nef), indicating persistence of native SH3-linker interaction in an active Hck conformation. Taken together, these data support the existence of multiple active conformations of Src family kinases that may generate unique downstream signals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210316     DOI: 10.1074/jbc.M508782200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Expression of a Src family kinase in chronic myelogenous leukemia cells induces resistance to imatinib in a kinase-dependent manner.

Authors:  Teodora Pene-Dumitrescu; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Multidomain assembled states of Hck tyrosine kinase in solution.

Authors:  Sichun Yang; Lydia Blachowicz; Lee Makowski; Benoît Roux
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

3.  Quantitative relation between intermolecular and intramolecular binding of pro-rich peptides to SH3 domains.

Authors:  Huan-Xiang Zhou
Journal:  Biophys J       Date:  2006-08-04       Impact factor: 4.033

4.  An examination of dynamics crosstalk between SH2 and SH3 domains by hydrogen/deuterium exchange and mass spectrometry.

Authors:  James M Hochrein; Edwina C Lerner; Anthony P Schiavone; Thomas E Smithgall; John R Engen
Journal:  Protein Sci       Date:  2005-12-01       Impact factor: 6.725

5.  On the importance of a funneled energy landscape for the assembly and regulation of multidomain Src tyrosine kinases.

Authors:  José D Faraldo-Gómez; Benoît Roux
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

Review 6.  Hydrogen-deuterium exchange mass spectrometry reveals folding and allostery in protein-protein interactions.

Authors:  Cesar A Ramirez-Sarmiento; Elizabeth A Komives
Journal:  Methods       Date:  2018-04-06       Impact factor: 3.608

7.  Computational study of the W260A activating mutant of Src tyrosine kinase.

Authors:  Yilin Meng; Benoît Roux
Journal:  Protein Sci       Date:  2015-07-18       Impact factor: 6.725

8.  Cooperative activation of Src family kinases by SH3 and SH2 ligands.

Authors:  Shalini S Yadav; W Todd Miller
Journal:  Cancer Lett       Date:  2007-08-24       Impact factor: 8.679

Review 9.  Structure and dynamic regulation of Abl kinases.

Authors:  Shoghag Panjarian; Roxana E Iacob; Shugui Chen; John R Engen; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2013-01-11       Impact factor: 5.157

10.  Partial cooperative unfolding in proteins as observed by hydrogen exchange mass spectrometry.

Authors:  John R Engen; Thomas E Wales; Shugui Chen; Elaine M Marzluff; Kerry M Hassell; David D Weis; Thomas E Smithgall
Journal:  Int Rev Phys Chem       Date:  2013-01-01       Impact factor: 4.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.